Literature DB >> 2878959

Response of carcinogen-altered mouse epidermal cells to phorbol ester tumor promoters and calcium.

H Hennings, D Michael, U Lichti, S H Yuspa.   

Abstract

Primary cultures of mouse epidermal cells are induced to terminally differentiate when extracellular calcium levels are increased to more than 0.1 mM. After carcinogen treatment, cellular foci can be selected that resist this calcium signal to terminally differentiate. Calcium causes these foci to stratify; however, in contrast to normal epidermis, DNA-synthesizing cells in these foci are found in the suprabasal cell layers as well as in basal cells. Cell lines derived from these foci may be considered to be putative initiated cells. Three of these cell lines, designated 308, D, and F, have been characterized for their response to calcium and phorbol ester tumor promoters. The formation of cornified cells and the activity of epidermal transglutaminase were utilized as markers of epidermal differentiation. Neither calcium nor the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) increased transglutaminase activity or cornification of any of the 3 lines. Proliferation was estimated by the [3H]thymidine labeling index, by incorporation of [3H]thymidine into DNA, and by a clonal growth assay. Unlike primary normal cultures, raising the calcium level of the medium did not markedly reduce the rate of proliferation of any of the 3 cell lines. In 2 of the lines, line 308 and line D, proliferation increased in response to TPA exposure. In line F, [3H]thymidine incorporation in confluent cultures was inhibited by TPA, while in cells plated at clonal densities, TPA was cytotoxic at doses of 5 ng/ml or higher. If these calcium-resistant epidermal cell lines correspond to initiated cells, their lack of sensitivity to the induction of terminal differentiation by TPA could account for their growth relative to normal cells. Those lines that also respond to stimulation of proliferation by TPA to a greater extent than normal cells would have a further growth advantage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2878959     DOI: 10.1111/1523-1747.ep12465014

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Regulatory role for Krüppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.

Authors:  Gen Nakanishi; Yong-Sik Kim; Takeshi Nakajima; Anton M Jetten
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

2.  Foxc1 Ablated Mice Are Anhidrotic and Recapitulate Features of Human Miliaria Sweat Retention Disorder.

Authors:  Chang-Yi Cui; Ryuga Ishii; Dean P Campbell; Marc Michel; Yulan Piao; Tsutomu Kume; David Schlessinger
Journal:  J Invest Dermatol       Date:  2016-09-01       Impact factor: 8.551

3.  Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.

Authors:  Jessica S Kelsey; Christophe Cataisson; Jinqiu Chen; Michelle A Herrmann; Mark E Petersen; David O Baumann; Kevin M McGowan; Stuart H Yuspa; Gary E Keck; Peter M Blumberg
Journal:  Mol Carcinog       Date:  2016-02-09       Impact factor: 4.784

4.  Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector.

Authors:  L Li; P S Lorenzo; K Bogi; P M Blumberg; S H Yuspa
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

5.  Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.

Authors:  Erika L Abel; Joe M Angel; Kaoru Kiguchi; John DiGiovanni
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

6.  Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

7.  TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2.

Authors:  Amy T Ku; Timothy M Shaver; Ajay S Rao; Jeffrey M Howard; Christine N Rodriguez; Qi Miao; Gloria Garcia; Diep Le; Diane Yang; Malgorzata Borowiak; Daniel N Cohen; Vida Chitsazzadeh; Abdul H Diwan; Kenneth Y Tsai; Hoang Nguyen
Journal:  Elife       Date:  2017-05-03       Impact factor: 8.140

8.  Targeting the cancer cell cycle by cold atmospheric plasma.

Authors:  O Volotskova; T S Hawley; M A Stepp; M Keidar
Journal:  Sci Rep       Date:  2012-09-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.